{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:12:42Z","timestamp":1793812362455,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019334","name":"Key Project of Science and Technology Development of Nanjing Medicine","doi-asserted-by":"publisher","award":["ZKX18014"],"award-info":[{"award-number":["ZKX18014"]}],"id":[{"id":"10.13039\/501100019334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cllc.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T15:54:33Z","timestamp":1670255673000},"page":"e94-e104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2345-5908","authenticated-orcid":false,"given":"Huiying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2022.11.011_bib0001","article-title":"Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments","author":"Ozcan","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.cllc.2022.11.011_bib0002","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.cllc.2022.11.011_bib0003","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with NSCLC with EGFR mutations","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.cllc.2022.11.011_bib0004","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jocn.2015.04.003","article-title":"Survival following Ommaya reservoir placement for neoplastic meningitis","volume":"22","author":"Roguski","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"1","key":"10.1016\/j.cllc.2022.11.011_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/107327481702400107","article-title":"Surgical Treatment for Leptomeningeal Disease","volume":"24","author":"Volkov","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.cllc.2022.11.011_bib0006","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3389\/fonc.2019.00838","article-title":"A pilot phase 1 study of intrathecal pemetrexed for refractory leptomeningeal metastases from non-small-cell lung cancer","volume":"9","author":"Pan","year":"2019","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2022.11.011_bib0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40272-018-0298-9","article-title":"the use of ommaya reservoirs to deliver central nervous system-directed chemotherapy in childhood acute lymphoblastic leukaemia","volume":"20","author":"Wilson","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"2","key":"10.1016\/j.cllc.2022.11.011_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00280-010-1522-7","article-title":"Safety and pharmacokinetics of intrathecal administration of pemetrexed in rats","volume":"68","author":"Sun","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.cllc.2022.11.011_bib0009","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jtho.2021.04.018","volume":"16","author":"Fan","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.cllc.2022.11.011_bib0010","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.21037\/apm-19-521","article-title":"Treatment response to intrathecal chemotherapy with pemetrexed via an Ommaya reservoir in EGFR-mutated leptomeningeal metastases from non-small cell lung cancer: a case report","volume":"9","author":"Li","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.cllc.2022.11.011_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200544010-00001","article-title":"Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis","volume":"44","author":"Fleischhack","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.cllc.2022.11.011_bib0012","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1148\/radiology.216.3.r00au37672","article-title":"Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers","volume":"216","author":"Courchesne","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.cllc.2022.11.011_bib0013","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00280-005-0036-1","article-title":"Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients","volume":"57","author":"Latz","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"10.1016\/j.cllc.2022.11.011_bib0014","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djp079","article-title":"Dose escalation methods in phase I cancer clinical trials","volume":"101","author":"Le Tourneau","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.cllc.2022.11.011_bib0015","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.21037\/apm-20-2086","article-title":"Multiple combination therapy based on intrathecal pemetrexed in non-small cell lung cancer patients with refractory leptomeningeal metastasis","volume":"9","author":"Miao","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.cllc.2022.11.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221078429","article-title":"A retrospective study of intrathecal pemetrexed combined with systemic therapy for leptomeningeal metastasis of lung cancer","volume":"21","author":"Geng","year":"2022","journal-title":"Technology in Cancer Res Treatment"},{"issue":"4","key":"10.1016\/j.cllc.2022.11.011_bib0017","first-page":"484","article-title":"Leptomeningeal metastases: a RANO proposal for response criteria","volume":"19","author":"Chamberlain","year":"2017","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.cllc.2022.11.011_bib0018","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-013-1055-0","article-title":"Pharmacokinetics and efficacy of pemetrexed in patients with brain or leptomeningeal metastases","volume":"112","author":"Kumthekar","year":"2013","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.cllc.2022.11.011_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11523-014-0326-9","article-title":"Erlotinib in combination with pemetrexed\/cisplatin for leptomeningeal metastases and cerebrospinal fluid drug concentrations in lung adenocarcinoma patients after gefitinib faliure","volume":"10","author":"Yang","year":"2015","journal-title":"Target Oncol"},{"issue":"5","key":"10.1016\/j.cllc.2022.11.011_bib0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cllc.2022.03.013","article-title":"Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal Disease","volume":"23","author":"Merkhofer","year":"2022","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.cllc.2022.11.011_bib0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11060-011-0655-9","article-title":"The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis","volume":"106","author":"Brastianos","year":"2012","journal-title":"J Neurooncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422002698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730422002698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:14:09Z","timestamp":1761506049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730422002698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1525730422002698"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2022.11.011","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, Pharmacokinetic and Clinical Activity of Intrathecal Chemotherapy With Pemetrexed via the Ommaya Reservoir for Leptomeningeal Metastases From Lung Adenocarcinoma: A Prospective Phase I Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}